Progress | Published:

What's in a face?


Genetic syndromes causing human facial abnormalities have been extensively studied from the clinical point of view. In these syndromes, distinctive facial features are frequently associated with specific defects of other organ systems, and the genes responsible must all play a significant part in normal development. In this paper genes causing craniofacial abnormalities, that have either been mapped or isolated, are reviewed

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1

    Dixon, J. et al. Positional cloning of a gene involved in the pathognesis of Treacher Collins syndrome. Nature Genet. 12, 130–136 (1996).

  2. 2

    Paavola, P., Salonen, R., Weissenbach, J. & Peltonen, L. The locus for Meckel syndrome with multiple congenital anomalies maps to chromosome 17q21–q24. Nature Genet. 11, 213–215 (1995).

  3. 3

    Erlebacher, A., Filvaroff, E.H., Gitelman, S.E. & Derynck, R. Towards a molecular understanding of skeletal development. Cell. 80, 371–378 (1995).

  4. 4

    Mulvihill, J.J. Craniofacial syndromes: no such thing as a single gene disease. Nature Genet. 9, 101–103 (1995).

  5. 5

    Dobyns, W.B., Reiner, O., Carrozzo, R. & Ledbetter, D.H., A human brain malformation associated with deletion of the LIS1 gene located at chromosome 17p13. J. Am. Mod. Assoc. 270, 2838–2842 (1993).

  6. 6

    Reiner, O. et al. Isolation of a Miller-Dieker lissencephaly gene containing G protein beta-subunit-like repeats. Nature. 364, 717–721 (1993).

  7. 7

    Hattori, M. et al. Miller-Dieker lissencephaly encodes a subunit of brain platelet-activating factor. Nature. 370, 216–218 (1994).

  8. 8

    Chong, S.S. et al. Systematic deletion analysis of MLS and ILS patients excludes a candidate gene and delineates the lissencephaly gene locus. Am. J. Hum. Genet. 57, A34 (1995).

  9. 9

    Muenke, M. Holoprosencephaly as a genetic model for normal craniofacial development. Dev. Biol. 5, 293–301 (1994).

  10. 10

    Muenke, M. et al. Linkage of a human brain malformation, familial holoprosencephaly, to chromosome 7 and evidence for genetic heterogeneity. Proc. Natl. Acad. Sci. USA. 91, 8102–8106 (1994).

  11. 11

    Muenke, M. et al. Physical mapping of the holoprosencephaly critical region in 21q22.3, exclusion of SIM2 as a candidate gene for holoprosencephaly, and mapping of SIM2 to a region of chromosome 21 important for Down syndrome. Am. J. Hum. Genet. 57, 1074–1079 (1995).

  12. 12

    Schell, U. et al. Molecular characterization of breakpoints in patients with holoprosencephaly and definition of the HPE2 critical region in 2p21. Hum. Mol. Genet. 5, 223–230 (1996).

  13. 13

    MacPherson, E., Estop, A. & Paulus-Thomas, J. Craniofrontonasal dysplasia in a girl with del (X)(p222). Am. J. Hum. Genet. 49 (Supp) A774 (1991).

  14. 14

    Robin, N. et al. Opitz syndrome is genetically heterogeneous, with one locus on Xp22, and a second on 22q11.2. Nature Genet. 11, 459–461 (1995).

  15. 15

    Vortkamp, A., Gessler, M. & Grzeschik, K.-.H. GLI3 zinc-finger gene interrupted by translocations in Greig syndrome families. Nature. 352, 539–540 (1991).

  16. 16

    Hui, C.-.C. & Joyner, A.L. A mouse model of Greig cephalopolysyndactyly syndrome: the extra-toes*J mutation contains an intragenic deletion of the Gli3 gene. Nature Genet. 3, 241–246 (1993).

  17. 17

    Brueton, L.A., Huson, S.M., Farren, B. & Winter, R.M. Oculodentodigital dysplasia and type III syndactyly: separate genetic entities or disease spectrum? J. Med. Genet. 27, 169–175 (1990).

  18. 18

    Hurvitz, S.A. et al. The facio-audio-symphalangism syndrome: report of a case and review of the literature. Clin. Genet. 28, 61–68 (1985).

  19. 19

    Brueton, LA et al. The acrocallosal syndrome and Greig syndrome are not allelic disorders. J. Med. Genet. 29, 635–637 (1992).

  20. 20

    Salonen, R. & Henva, R. Syndrome of the month: hydrolethalus syndrome. J. Med. Genet. 27, 756–759 (1990).

  21. 21

    Allanson, J.E. et al. Noonan syndrome: the changing phenotype. Am. J. Med. Genet. 21, 507–514 (1985).

  22. 22

    Jamieson, C.R. et al. Mapping a gene for Noonan syndrome to the long arm of chromosome 12. Nature Genet. 8, 357–360 (1994).

  23. 23

    Ewart, A.K. et al. Hemizygosity at the elastin locus in a developmental disorder, Williams syndrome. Nature Genet. 5, 11–16 (1993).

  24. 24

    Lowery, M.C. et al. Strong correlation of elastin deletions, detected by FISH, with Williams syndrome: evaluation of 235 patients. Am. J. Hum. Genet. 57, 49–53 (1995).

  25. 25

    Driscoll, D.A. Genetic basis of DiGeorge and velocardiofacial syndromes. Curr. Opin. Pediatr. 6, 702–706 (1994).

  26. 26

    Budarf, M.L. et al. Cloning a balanced translation associated with DiGeorge syndrome and identification of a disrupted candidate gene. Nature Genet. 10, 269–278 (1995).

  27. 27

    Holder, S.E., Winter, R.M., Kamath, S. & Scambler, P.J. Velocardiofacial syndrome in a mother and daughter: variability of the clinical phenotype. J. Med. Genet. 30, 825–827 (1993).

  28. 28

    Francomano, C.A. et al. The gene for Ellis van Creveld syndrome maps to chromosome 4p16. Am. J. Hum. Genet. 57, A191 (1995).

  29. 29

    Badame, A.J., Arch. Dermatol. 125, 540–544 (1989).

  30. 30

    Henning, K.A. et al. The Cockayne syndrome group A gene encodes a WD repeat protein that interacts with CSB protein and a subunit of RNA polymerase IIFIIH. Cell. 182, 555–564 (1995).

  31. 31

    Cleaver, J.E. It was a very good year for DMA repair. Cell. 76, 1–4 (1994).

  32. 32

    Goto, M. et al. Genetic linkage of Werner's syndrome to five markers on chromosome 8. Nature. 355, 735–738 (1992).

  33. 33

    Ellis, N.A. et al. The Bloom's syndrome gene product is homologous to RecQ helicases. Cell. 83, 655–666 (1995).

  34. 34

    Pasteris, N.G. et al. Isolation and characterization of the faciogenital dysplasia (Aarskog-Scott syndrome) gene: a putative Rho-Rac guanine nucleotide exchange factor. Cell. 79, 669–678 (1994).

  35. 35

    Wilkie, A.O.M. et al. Clinical features and molecular analysis of the alpha thalassemia/mental retardation syndromes. II. Cases without detectable abnormality of the alpha globin complex. Am. J. Hum. Genet. 46, 1127–1140 (1990).

  36. 36

    Gibbons, R.J., Picketts, D.J., Villard, L. & Higgs, D.R. Mutations in a putative global transcriptional regulator cause X-linked mental retardation with alpha-thalassemia (ATR-X syndrome). Cell. 80, 837–846 (1995).

  37. 37

    Hennekam, R.C.M. Rubinstein-Taybi syndrome: a history in pictures. Clin. Dysmorphol. 2, 87–92 (1993).

  38. 38

    Breuning, M.H. et al. Rubinstein-Taybi syndrome caused by submicroscopic deletions within 16p13.3. Am. J. Hum. Genet. 52, 249–254 (1993).

  39. 39

    Petrij, F. et al. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBR. Nature. 376, 348–351 (1995).

  40. 40

    D'Arcangelo, G. & Curran, T. Smart transcription factors. Nature. 376, 292–293 (1995).

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Further reading